Gerben Duns
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Renal and related cancers
- Cancer-related gene regulation
Papers in
-
- Renal and related cancers 3
- Epigenetics and DNA Methylation 3
-
- Lymphoma Diagnosis and Treatment 8
- Co-authors
- Klaas Kok (8 shared papers)Anke van den Berg (7 shared papers)Robert M.W. Hofstra (3 shared papers)Harry Hollema (2 shared papers)Helga Westers (1 shared paper)Jun Li (1 shared paper)Rolf H. Sijmons (1 shared paper)Debora de Jong (3 shared papers)
- Journals
- Blood (7 papers)Blood Advances (2 papers)Cancer Research (1 paper)Scientific Reports (1 paper)BMC Medical Genomics (1 paper)
- Partner nations
- CanadaNetherlandsUnited States
In The Last Decade
Gerben Duns
20 papers receiving 612 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 218
- Molecular Biology 463
- Pulmonary and Respiratory Medicine 140
- Pathology and Forensic Medicine 70
- Genetics 32
Countries citing papers authored by Gerben Duns
This map shows the geographic impact of Gerben Duns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerben Duns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerben Duns more than expected).
Fields of papers citing papers by Gerben Duns
This network shows the impact of papers produced by Gerben Duns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerben Duns. The network helps show where Gerben Duns may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerben Duns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 187 | |
| 2 | 2016 | 113 | |
| 3 | 2009 | 92 | |
| 4 | 2012 | 57 | |
| 5 | 2018 | 48 | |
| 6 | 2017 | 31 | |
| 7 | 2012 | 25 | |
| 8 | 2020 | 22 | |
| 9 | 2022 | 11 | |
| 10 | 2023 | 10 | |
| 11 | 2024 | 7 | |
| 12 | 2019 | 4 | |
| 13 | 2024 | 2 | |
| 14 | 2023 | 2 | |
| 15 | 2024 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2009 | 1 | |
| 18 | 2019 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2022 | 1 |
About Gerben Duns
Gerben Duns is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Genetics, Cancer Research and Oncology, having authored 22 papers that have together received 619 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (6 papers), MicroRNA in disease regulation (3 papers), Acute Myeloid Leukemia Research (3 papers), Renal and related cancers (3 papers), Viral-associated cancers and disorders (3 papers), Epigenetics and DNA Methylation (3 papers) and Renal cell carcinoma treatment (3 papers). The work is most often cited by research in Cancer Research (218 citations), Molecular Biology (463 citations), Pulmonary and Respiratory Medicine (140 citations), Pathology and Forensic Medicine (70 citations) and Genetics (32 citations). Gerben Duns has collaborated with scholars based in Canada, Netherlands and United States. Frequent co-authors include Klaas Kok, Anke van den Berg, Robert M.W. Hofstra, Harry Hollema, Helga Westers, Jun Li, Rolf H. Sijmons, Debora de Jong, Aly Karsan and Ody C.M. Sibon. Their work appears in journals such as Blood, Blood Advances, Cancer Research, Scientific Reports and BMC Medical Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.